Nidhy P. Varghese, MD, FAAP

Personal Statement

As a pediatric pulmonologist, my specific area of interest is pulmonary hypertension. I am actively involved in a number of national and international organizations dedicated to the care of children who suffer from this disease. It is my honor to advocate for pediatric PH, strive to deliver the best care possible and educate the world about PH. My other areas of interest include chronic respiratory failure and pulmonary complications of sickle cell disease. Family-centered care and transparency are big parts of my care delivery, to ensure that your child thrives.

Clinical Interests:

1. Pulmonary hypertension

2. Chronic respiratory failure

3. Pulmonary complications of sickle cell disease

4. General pulmonology

Research Interests:

1. Pulmonary hypertension, pulmonary vascular disease

2. Chronic respiratory failure

3. Pulmonary complications of sickle cell disease

---

Education

,

,

,

Organizations

,

,

,

,

,

,

* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.

Varghese NP, Tillman RH, Keller RL. Pulmonary hypertension is an important co-morbidity in developmental lung diseases of infancy: Bronchopulmonary dysplasia and congenital diaphragmatic hernia. Pediatr Pulmonol 2021 Mar;56(3):670-677.

Birjiniuk A, Glinton KE, Villafranco N, Boyer S, Laufman J, Mizerik E, Scott D, Elsea SH, Galambos C, Varghese NP, Scaglia F. Multiple mitochondrial dysfunction syndrome 1: An unusual cause of developmental pulmonary hypertension. Am J Med Genet A 2020 Apr;182 (4):755-761. doi: 10.1002/ajmg.a.61491. Epub 2020 Jan 22. Published as a result of work done at Baylor College of Medicine.

Varghese N, Rios D. Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia: A Review. Pediatr Allergy Immunol Pulmonol 2019 Dec 1;32(4):140-148.

Kanaan U, Varghese NP, Coleman RD, Huckaby J, Lawrence P, Jorgensen LO, Miller-Reed K, Day RW, Mallory GB, Ivy DD. Oral treprostinil use in children: a multicenter, observational experience. Pulm Circ. 2019 Jul-Sep; 9(3): 2045894019862138. Published as a result of work done at Baylor College of Medicine.

Goldberg JF, Jensen CL, Krishnamurthy R, Varghese NP, Justino H. Pulmonary Vein Stenosis with Collateralization Via Esophageal Varices: Long-Term Follow-up after Successful Treatment with Drug-Eluting Stent. Congen Heart Dis 2018 Jan;13(1):124-130. Published as a result of work done at Baylor College of Medicine.

Darland LK, Dinh KL, Kim S, Placencia JL, Varghese NP, Ruiz F, Mallory GB, Fernandes CJ. Evaluating the safety of intermittent intravenous sildenafil in infants with pulmonary hypertension. Pediatr Pulmonol 2016 Jun 24. Published as a result of work done at Baylor College of Medicine.

Wang G, Fan R, Ji R, Zou W, Penny DJ, Varghese NP, Fan Y. Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report. BMC Pulm Med 2016; 16:17. Published as a result of work done at Baylor College of Medicine.

Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, Lyons JJ, Engelhardt KR, Zhang Y, Topcagic N, Roberson ED, Matthews H, Verbsky JW, Dasu T, Vargas-Hernandez A, Varghese N, McClain KL, Karam LB, Nahmod K, Makedonas G, Mace EM, Sorte HS, Perminow G, Rao VK, O'Connell MP, Price S, Su HC, Butrick M, McElwee J, Hughes JD, Willet J, Swan D, Xu Y, Santibanez-Koref M, Slowik V, Dinwiddie DL, Ciaccio CE, Saunders CJ, Septer S, Kingsmore SF, White AJ, Cant AJ, Hambleton S, Cooper MA. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 2015 Jan 22; 125(4):591-9. Published as a result of work done at Baylor College of Medicine.